Cargando…
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1982
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011195/ https://www.ncbi.nlm.nih.gov/pubmed/6291565 |
| _version_ | 1782136480521519104 |
|---|---|
| author | McNally, N. J. |
| author_facet | McNally, N. J. |
| author_sort | McNally, N. J. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2011195 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1982 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20111952009-09-10 The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. McNally, N. J. Br J Cancer Research Article Nature Publishing Group 1982-10 /pmc/articles/PMC2011195/ /pubmed/6291565 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article McNally, N. J. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title | The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title_full | The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title_fullStr | The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title_full_unstemmed | The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title_short | The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| title_sort | effect of misonidazole combined with wr2721 on tumour response and leucopenia due to cyclophosphamide or melphalan. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011195/ https://www.ncbi.nlm.nih.gov/pubmed/6291565 |
| work_keys_str_mv | AT mcnallynj theeffectofmisonidazolecombinedwithwr2721ontumourresponseandleucopeniaduetocyclophosphamideormelphalan AT mcnallynj effectofmisonidazolecombinedwithwr2721ontumourresponseandleucopeniaduetocyclophosphamideormelphalan |